Insider buying last 90 days
No open-market insider purchases were filed for DLB in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every DLB insider filing, plotted on the chart in Gekko.Open DLB in Gekko
NYSE: DLB
Dolby Laboratories (DLB) Stock Analysis & Forecast
Sep 28 close
$58.19−0.37 (−0.6%)
Gekko Brief
AI summaryDolby's week centers on an expanded partnership with Meta, extending Dolby Atmos and Dolby Vision across Meta's AI glasses, Instagram and VR products, broadening the company's digital content footprint. This follows commentary from the last earnings call highlighting momentum in Atmos, Vision, imaging patents and the Video Distribution Program, with new licensees including Meta and Alibaba noted at the time. Separately, DLB has appeared in comparative coverage alongside Zscaler, weighing analyst recommendations, valuation and other metrics between the two names.
The stock closes at $58.19, down 0.6%, sitting below both its 50-day average of $59.40 and its 200-day average of $59.90, with the shorter average also under the longer one. The GekkoIndex reads 62.4, placing DLB in the Accumulation zone, though the reading has slipped 4 points over five sessions. Price sits 17% below the Gekko Fair Value of $70.14.
The next earnings date falls on 17 November, 49 days out and beyond a typical 20-day holding window; the prior report on 30 July produced an 11.9% reaction on a beat, part of a run of 7 beats in 8 quarters. No insider, Congress or unusual options activity appears in their respective windows. Seasonality over the next 20 trading days has averaged -2.5% across 5 years, with 0 of those years positive, a pattern worth noting alongside the current gap to fair value.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Dolby Laboratories price vs fair value
Close $58.19200-day averageGekko Fair Value $70.14
Dolby Laboratories quick facts
- Market cap
- $5.54B
- P/E ratio
- 24.9
- Forward P/E
- 12.6
- EPS, TTM
- $2.35
- Revenue, TTM
- $1.35B
- Profit margin
- 16.7%
- Dividend yield
- 2.50%
- Beta
- 0.80
- Volume
- 621,295 avg 984,812
- 1-year return
- −18.5%
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±4.2%
- 50-day average
- $59.40
- 200-day average
- $59.90
- Next earnings
- Nov 17 after close
- Shares outstanding
- 59.42M
Dolby Laboratories swing-trade checklist
Dolby Laboratories scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $58.19 is below the 50-day ($59.40) and 200-day ($59.90) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
62.4, Accumulation
Reading 62.4 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
17.0% below
Price is 17% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 49 days
Next report Nov 17, 2026, 49 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−2.5% on average
From this point in the calendar, the next 20 trading days averaged −2.5% over 5 years, rising in 0 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Dolby Laboratories stock chart and price history
Dolby Laboratories closed at $58.19 on Sep 28, 2026, −18.5% over the past year, inside a 52-week range of $48.26 to $73.01.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.8%
- 3 months
- +11.6%
- 6 months
- +0.3%
- 1 year
- −18.5%
The full DLB chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DLB in Gekko
Follow Dolby Laboratories through every session
Put DLB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track DLB in GekkoFree for 7 days. No credit card required.
About Dolby Laboratories
Dolby Laboratories creates audio and imaging technologies used to improve sound and picture quality across entertainment and communication systems, spanning movie theaters, television broadcasts, streaming platforms, mobile devices and home entertainment setups. It is widely recognized for its audio and video coding formats, including AAC, AVC, Dolby AC-4, Dolby Atmos, Dolby Digital and its variants, Dolby TrueHD, HEVC, and imaging and voice technologies such as Dolby Vision and Dolby Voice, which together shape how sound and visuals are delivered on many types of playback equipment.
The company generates revenue partly by licensing these technologies to other manufacturers and media platforms, while also designing and building physical products such as cinema servers, processors, amplifiers, loudspeakers and video conferencing equipment. It provides supporting services for theatrical and television production, covering exhibition, broadcast operations and home entertainment needs. Its customer base includes film studios, content creators, post-production houses, cinema operators, broadcasters and video game developers, reached both directly and through a worldwide network of dealers and distributors.
Dolby Laboratories was founded in 1965 and is headquartered in San Francisco, California. Its shares are listed on the NYSE under the ticker DLB.
- Listed
- NYSE
- Sector
- Technology services
- Industry
- Packaged software
- Website
- dolby.com
Dolby Laboratories GekkoIndex: the smart money zone
Dolby Laboratories’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.4, in the Accumulation zone, down 4 points over five sessions.
62.4Accumulation
Down 4 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +0.7% | +2.6% | ||
| Accumulation (current zone) | 297 | +0.1% | +1.1% | ||
| Neutral | 324 | −0.6% | −2.8% | ||
| Distribution | 12 | +0.4% | −0.6% | ||
| Selling | 1 | Too few readings yet | |||
Average DLB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the DLB price, zone by zone.Track DLB in Gekko
Is Dolby Laboratories stock overvalued? Gekko Fair Value
Dolby Laboratories trades 17.0% below Gekko Fair Value of $70.14, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Dolby Laboratories shares are worth, recalculated every trading day.
$70.14
Gekko Fair Value, Sep 29, 2026
17.0% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open DLB in Gekko
Dolby Laboratories insider and Congress trading
No open-market insider purchases were filed for Dolby Laboratories, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in DLB were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for DLB, plotted on the chart in Gekko.Open DLB in Gekko
Buybacks
Dolby Laboratories has been buying back its own shares.
- Latest authorization
- $350.0M, Jul 30, 2026
- Bought back, quarter ended Jun 26, 2026
- $65.89M
- As a share of market cap
- 1.19%
- Trailing four quarters
- $269.2M
From company filings.
Dolby Laboratories earnings: next date and track record
Dolby Laboratories reports on Nov 17, 2026, after the close (49 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 17, 2026
Expected after the close, 49 days away
- EPS estimate
- $1.19
- Revenue estimate
- $372.8M
7 of 8reports beat the EPS estimate
±7.5%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Dolby reported Q3 FY26 revenue of $305 million and non-GAAP EPS of $0.69, which were within prior guidance. Management highlighted strong momentum entering Q4 driven by growth in Dolby Atmos, Dolby Vision, imaging patents, and the Video Distribution Program (VDP), noting major new VDP licensees including Meta and Alibaba. The company is expanding beyond device licensing into content partnerships with a target of 10% of revenue from content partners by FY28. They generated ~$167 million in operating cash flow, repurchased $65 million of stock this quarter and increased the buyback authorization by $350 million; the dividend was raised 9% to $0.36. A small $4 million restructuring charge was recorded. Management expects strong sequential growth in Q4 and provided detailed Q4 guidance. Management discussed product progress (Dolby Vision 2.0, OptiView low-latency streaming and targeted ads), automotive adoption, and potential headwinds from memory cost inflation affecting mobile and PC end markets.
- Guidance
- Q4 FY26 revenue: $362M - $392M (licensing $335M - $365M). Non-GAAP gross margin ~90%. Non-GAAP operating expenses $195M - $205M. Non-GAAP EPS $1.13 - $1.28. Company narrowed full-year range while keeping midpoint unchanged and expects strong sequential growth in Q4 driven by pipeline momentum.
- Risks flagged
- Management cited macroeconomic events, supply chain issues, inflation, changes in consumer spending, geopolitical instability, and memory price increases (which particularly affect mobile and PC BOMs) as risks that could impact future performance. They also noted potential quarterly volatility from timing of minimum volume commitments and true-ups. A $4M restructuring charge reflects organizational alignment risk.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.43 est $0.40 | $305.0M est $312.0M | +11.9% |
| Apr 30, 2026 | $0.00 est $1.34 | $395.6M est $385.8M | −9.2% |
| Jan 29, 2026 | $1.06 est $0.99 | $346.7M est $341.3M | +4.9% |
| Nov 18, 2025 | $0.99 est $0.70 | $307.0M est $305.8M | +0.7% |
| Jul 31, 2025 | $0.78 est $0.71 | $315.5M est $305.8M | −7.4% |
| May 1, 2025 | $1.34 est $1.27 | $369.6M est $305.2M | −2.5% |
| Jan 29, 2025 | $1.14 est $0.98 | $357.0M est $383.8M | +8.3% |
| Nov 19, 2024 | $0.81 est $0.70 | $304.8M est $307.9M | +14.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Dolby Laboratories stock forecast and analyst price targets
Analysts’ average 12-month price target for Dolby Laboratories is $79.00, +35.8% from the last close, from 3 firms rating the stock in the last 90 days.
$79.00consensus 12-month target, +35.8% from the last close
Now $58.19Avg $79.00
Low $85High $90
Each firm’s latest rating in the last 90 days: 3 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 27 | William Blair | — | — |
| Jul 31 | Rosenblatt Securities | $85 | +46.1% |
| Jul 31 | Barrington | $90 | +54.7% |
| Jul 30 | William Blair | — | — |
| Jul 14 | Barrington | $90 | +54.7% |
+1.1%average 20-day move after past Accumulation readings
−2.5%average move over the next 20 trading days in the last 5 years
±3.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Dolby Laboratories seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Dolby Laboratories averaged −2.5% across the last 5 years, rising in 0 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.0% | 5 of 5 |
| Next 10 trading days | −1.6% | 1 of 5 |
| Next 15 trading days | −0.4% | 2 of 5 |
| Next 20 trading days | −2.5% | 0 of 5 |
| Next 30 trading days | +1.1% | 2 of 5 |
For scale, DLB’s typical 20-trading-day move in either direction is about 4.2%.
Dolby Laboratories market cap and key statistics
Dolby Laboratories’s market cap is $5.54B, with a P/E ratio of 24.9 and revenue of $1.35B over the last twelve months.
Valuation
- Market cap
- $5.54B
- P/E ratio
- 24.9
- Forward P/E
- 12.6
- EPS, TTM
- $2.35
- Gekko Fair Value
- $70.14
Trading
- Volume
- 621,295
- Avg volume, 20 days
- 984,812
- 52-week high
- $73.01
- 52-week low
- $48.26
- Shares outstanding
- 59.42M
Financials
- Revenue, TTM
- $1.35B
- Profit margin
- 16.7%
- Return on equity
- 8.8%
- Quarterly earnings growth, YoY
- −37.5%
Risk and income
- Beta
- 0.80
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±4.2%
- Dividend yield
- 2.50%
Dolby Laboratories stock news this week
4 headlines about Dolby Laboratories from the past week, newest first, each linking to the publisher.
- Dolby Expands Meta Partnership With Atmos and Vision Across DevicesZacks Investment Research, Sep 24
- Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)Defense World, Sep 24
- Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemGuruFocus, Sep 23
- Dolby Laboratories, Inc. (DLB) Stock Price, News, Quote & HistoryYahoo! Finance Canada, Sep 23
Dolby Laboratories peers
Dolby Laboratories’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.3% above |
| PLTRPalantir Technologies | Neutral | 15.7% above |
| ORCLOracle | Accumulation | 25.9% below |
| PANWPalo Alto Networks | Neutral | 16.1% above |
| CRWDCrowdStrike | Neutral | 27.2% above |
| CRMSalesforce | Neutral | 5.9% below |
A peer links to its own page where one exists.
Dolby Laboratories stock FAQ
What is Dolby Laboratories’s market cap?
Dolby Laboratories’s market cap is $5.54B at the Sep 28, 2026 close of $58.19, with 59.42M shares outstanding. The shares trade on a P/E ratio of 24.9.
What is the Dolby Laboratories stock forecast?
The consensus analyst 12-month price target for Dolby Laboratories is $79.00, +35.8% from the last close. Of the 3 firms that rated the stock in the last 90 days, 3 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Dolby Laboratories stock overvalued or undervalued?
On Gekko’s estimate Dolby Laboratories is undervalued: the Sep 28, 2026 close of $58.19 is 17.0% below Gekko Fair Value of $70.14. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Dolby Laboratories report earnings next?
Dolby Laboratories is expected to report on Nov 17, 2026, after the market closes (49 days away). Analysts expect earnings of $1.19 per share on revenue of $372.8M. Dolby Laboratories beat the earnings estimate in 7 of its last 8 reports, moving 7.5% on average across the report.
What is Dolby Laboratories’s 52-week high and low?
Dolby Laboratories’s 52-week high is $73.01 and its 52-week low is $48.26; it closed at $58.19 on Sep 28, 2026, −18.5% over the past year. Over the last five years the shares peaked at $96.85 on Jan 3, 2022.
Is Dolby Laboratories stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Dolby Laboratories the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.